Health
Irish medical chief says use of AstraZeneca Covid jab should be suspended
Use of the Oxford-AstraZeneca Covid-19 vaccine should be suspended following reports of serious post-jab blood clots in Norway, Ireland’s deputy medical chief said.
Irish authorities have been pushing the pharmaceutical giant to speed up its vaccine supplies to the Republic, where cases per million people exceeded the UK’s figures during the peak of the January wave.
But now, deputy chief medical officer Dr Ronan Glynn said Ireland will act on a ‘precautionary principle’ and pause the AstraZeneca rollout following reports of ‘serious blood clotting events’ in Norway.
It will join Denmark, Norway and Iceland in temporarily halting all AstraZeneca vaccinations.
So far, more than 11 million doses of the Oxford jab have been administered in the UK alone, with countless more distributed worldwide.
Out of the millions of jabs already given, fewer than 50 cases of blood-related issues have been reported post-vaccine, with no confirmed causal link.
AstraZeneca, the World Health Organization and EU regulators have all rejected the blood clot fears.
Use of the AstraZeneca Covid-19 vaccine should be suspended following reports of serious post-jab blood clots in Norway, Ireland’s deputy medical chief said. Pictured: Daily confirmed Covid cases per million people in Ireland and the UK
Irish authorities have been pushing the pharmaceutical giant to speed up its jab supplies to the Republic after Boris Johnson made it clear that Britain would not send its vaccines to Ireland until people in the UK have had the jab. Pictured: A vaccine centre in Dublin
Deputy chief medical officer Dr Ronan Glynn said Ireland will act on a ‘precautionary principle’ and pause the AstraZeneca rollout following reports of ‘serious blood clotting events’ in Norway
Norwegian health authorities confirmed that three healthcare workers who had the AstraZeneca jab (file image) were being treated in hospital for bleeding, blood clots and a low count of blood platelets
Norwegian health authorities confirmed that three healthcare workers who had the AstraZeneca jab were being treated in hospital for bleeding, blood clots and a low count of blood platelets.
Dr Glynn said: ‘This recommendation has been made following a report from the Norwegian Medicines Agency of four new reports of serious blood clotting events in adults after vaccination with Covid-19 vaccine AstraZeneca.
‘It has not been concluded that there is any link between the Covid-19 vaccine AstraZeneca and these cases.
‘However, acting on the precautionary principle, and pending receipt of further information, the National Immunisation Advisory Committee (NIAC) has recommended the temporary deferral of the Covid-19 vaccine AstraZeneca vaccination programme in Ireland.’
Norway halted the rollout of the AstraZeneca vaccine on Thursday, following a similar move by Denmark. Iceland later followed suit.
All three individuals in hospital in Norway for conditions including blood clots were under the age of 50. The Government were notified on Saturday.
Senior doctor at the Norwegian Medicines Agency Sigurd Hortemo told a news conference this week: ‘We do not know if the cases are linked to the vaccine.’
The European medicine regulator, the European Medicines Agency (EMA), would investigate the three incidents, Hortemo said.
Medical Director at the Norwegian Medicines Agency Steinar Madsen said: ‘They have very unusual symptoms: bleeding, blood clots and a low count of blood platelets.
‘They are quite sick […] We take this very seriously.’
Meanwhile, the EMA reported one person in Austria was diagnosed with blood clots and died 10 days after vaccination – but it stressed there is ‘currently no indication that vaccination has caused these conditions’.
A further patient was admitted to hospital in Austria with pulmonary embolism – a blockage in the arteries in the lungs – after being vaccinated, while one death involving a blood clot was reported in Denmark.
A 50-year-old man is also thought to have died in Italy from deep vein thrombosis (DVT), while there has been an unconfirmed report of another death in the country.
Italy also followed Austria, Estonia, Latvia, Luxembourg and Lithuania in banning jabs from one particular batch of one million AstraZeneca vaccines, which was sent to 17 countries, after reports that a 49-year-old nurse died soon after getting one of the jabs.
Earlier this week, EU regulators confirmed they are looking into 30 cases of blood clots among nearly five million people who have had a dose of the vaccine.
Ireland’s governing coalition has been under fire over the speed of its vaccination response.
Norway halted the rollout of the AstraZeneca vaccine (file image) on Thursday, following a similar move by Denmark. Iceland later followed suit
Around 600,000 doses of vaccine – across all manufacturers – have so far been delivered.
That includes the most elderly, those in nursing homes and healthcare workers.
The EMA has initiated an urgent review of all blood clotting events occurring with the AstraZeneca vaccine to determine if there is a possible safety risk.
A statement from Ireland’s Health Products Regulatory Authority (HPRA) said: ‘To date, the HPRA has received a small number of reports associated with blood clots following vaccination with the AstraZeneca vaccine.
‘However, it has not received any reports of the nature of those described by the Norwegian Medicines Agency.
‘We will continue to monitor national reports very closely and continue to encourage the reporting of any suspected side-effect following vaccination with a Covid-19 vaccine.’
It said there is currently no indication that vaccination was the cause of these events and there may be alternative unrelated explanations for their occurrence.
The authority added: ‘However, the safety of the public is of the utmost importance, and it is essential that reports of potential safety concerns, even if very rare, are rigorously and swiftly investigated so that the public can be reassured and if required, appropriate action can be taken.’
The EMA are looking into 30 cases of blood clots among nearly five million people who have had a dose of the vaccine.
The preliminary assessment of similar events published by the EMA on 11 March found the number of blood clotting in vaccinated people was no higher than the number seen in the general population.
A thorough analysis of all relevant reports will be performed, including those newly notified from Norway, authorities said.
And AstraZeneca said an analysis of its safety data covering reported cases from over 17 million vaccine doses given had shown no evidence of an increased risk of pulmonary embolism, deep vein thrombosis or thrombocytopenia – having low levels of platelets.
‘In fact, the reported numbers of these types of events for Covid-19 Vaccine AstraZeneca are not greater than the number that would have occurred naturally in the unvaccinated population,’ a company spokeswoman said.
Such trends or patterns were also not observed during clinical trials for the vaccine, she added.
Around 600,000 doses of vaccine – across all manufacturers – have so far been delivered.
That includes the most elderly, those in nursing homes and healthcare workers.
AstraZeneca was approved for use early in the UK. Northern Ireland has made proportionately faster progress than the Republic in reaching the most vulnerable.
Irish Taoiseach Micheal Martin held ‘positive’ discussions with AstraZeneca chief executive officer Pascal Soriot on Friday evening.
He has expressed frustration at the failure of the company to meet delivery schedules for inoculations.
Ireland’s Minister of State for Mental Health and Older people has said Ireland ‘is still on track’ to have all over-70s vaccinated by mid-May with the supplies they have received to date, despite disruption from AstraZeneca.
Earlier this week, AstraZeneca dismissed concerns that its Covid-19 vaccine is linked to blood clots – joining the WHO, No 10 and EU regulators in rejecting the fears that have led several European countries to suspend their use of the jab.
The pharma giant said its analysis of more than 10million records showed there was ‘no evidence of an increased risk’ in any age group or any batch of doses, after Austria and others black-listed a particular shipment over fears of side-effects.
‘In fact, the observed number of these types of events are significantly lower in those vaccinated than would be expected among the general population,’ the firm said.
Austria, Bulgaria, Estonia, Latvia, Lithuania and Luxembourg have suspended one batch of doses after a 49-year-old nurse died soon after getting one of the jabs.
But AstraZeneca’s findings today match those of the EU safety panel which says there is ‘no indication’ the nurse’s death was caused by side-effects from the vaccine and found that the batch in question is ‘unlikely’ to be defective.
Despite Austria’s concerns, chancellor Sebastian Kurz sought to rally support for the AstraZeneca shot today by saying that he himself would be injected with it.
Kurz, one of the world’s youngest leaders at 34, said he would take the jab in order to ‘show that I trust this vaccine’ which has become an unloved choice in Europe after top officials feuded with AstraZeneca and questioned the shot’s effectiveness.
Germany and France are pressing ahead with AstraZeneca jabs, rejecting the blood clot fears, after Downing Street yesterday urged Britons to keep taking the shots.
WHO spokeswoman Margaret Harris also weighed in by telling reporters: ‘Yes, we should continue using the AstraZeneca vaccine. There is no indication to not use it.’
‘AstraZeneca is an excellent vaccine, as are the other vaccines that are being used,’ she said at a briefing in Geneva.
No 10 has insisted the jab is safe and that Britons should continue to take it, pointing to the success the vaccination programme is having.
The PM’s office said: ‘We’ve been clear that it’s both safe and effective, and when people are asked to come forward and take it, they should do so in confidence.’
‘And in fact you’re starting to see the results of the vaccine programme in terms of the (lower) number of cases we’re seeing across the country, the number of deaths, number of hospitalisations.’
.
What Are The Main Benefits Of Comparing Car Insurance Quotes Online
LOS ANGELES, CA / ACCESSWIRE / June 24, 2020, / Compare-autoinsurance.Org has launched a new blog post that presents the main benefits of comparing multiple car insurance quotes. For more info and free online quotes, please visit https://compare-autoinsurance.Org/the-advantages-of-comparing-prices-with-car-insurance-quotes-online/ The modern society has numerous technological advantages. One important advantage is the speed at which information is sent and received. With the help of the internet, the shopping habits of many persons have drastically changed. The car insurance industry hasn't remained untouched by these changes. On the internet, drivers can compare insurance prices and find out which sellers have the best offers. View photos The advantages of comparing online car insurance quotes are the following: Online quotes can be obtained from anywhere and at any time. Unlike physical insurance agencies, websites don't have a specific schedule and they are available at any time. Drivers that have busy working schedules, can compare quotes from anywhere and at any time, even at midnight. Multiple choices. Almost all insurance providers, no matter if they are well-known brands or just local insurers, have an online presence. Online quotes will allow policyholders the chance to discover multiple insurance companies and check their prices. Drivers are no longer required to get quotes from just a few known insurance companies. Also, local and regional insurers can provide lower insurance rates for the same services. Accurate insurance estimates. Online quotes can only be accurate if the customers provide accurate and real info about their car models and driving history. Lying about past driving incidents can make the price estimates to be lower, but when dealing with an insurance company lying to them is useless. Usually, insurance companies will do research about a potential customer before granting him coverage. Online quotes can be sorted easily. Although drivers are recommended to not choose a policy just based on its price, drivers can easily sort quotes by insurance price. Using brokerage websites will allow drivers to get quotes from multiple insurers, thus making the comparison faster and easier. For additional info, money-saving tips, and free car insurance quotes, visit https://compare-autoinsurance.Org/ Compare-autoinsurance.Org is an online provider of life, home, health, and auto insurance quotes. This website is unique because it does not simply stick to one kind of insurance provider, but brings the clients the best deals from many different online insurance carriers. In this way, clients have access to offers from multiple carriers all in one place: this website. On this site, customers have access to quotes for insurance plans from various agencies, such as local or nationwide agencies, brand names insurance companies, etc. "Online quotes can easily help drivers obtain better car insurance deals. All they have to do is to complete an online form with accurate and real info, then compare prices", said Russell Rabichev, Marketing Director of Internet Marketing Company. CONTACT: Company Name: Internet Marketing CompanyPerson for contact Name: Gurgu CPhone Number: (818) 359-3898Email: [email protected]: https://compare-autoinsurance.Org/ SOURCE: Compare-autoinsurance.Org View source version on accesswire.Com:https://www.Accesswire.Com/595055/What-Are-The-Main-Benefits-Of-Comparing-Car-Insurance-Quotes-Online View photos
Pictures Credit
to request, modification Contact us at Here or [email protected]